Skip to main content

Table 1 Baseline characteristics of the included participants

From: Effect of glycemic status on myocardial deformation and microvascular function in uncomplicated pediatric type 1 diabetes mellitus: cardiac magnetic resonance imaging

 

Controls (n = 35)

Type 1 diabetes mellitus

p

HbA1c < 7.0% (n = 25)

HbA1c ≥ 7.0% (n = 75)

Age, years

10.4 ± 2.6

11.2 ± 3.3

13.1 ± 3.1

0.133

Male, n (%)

20 (55.6)

11 (44.0)

13 (44.8)

0.342

Height, cm

144.2 ± 15.9

147.4 ± 16.5

154.3 ± 14.1

0.114

Weight, kg

37.8 ± 13.3

40.4 ± 15.3

44.1 ± 14.0

0.323

BSA, m2

1.2 ± 0.3

1.3 ± 0.3

1.4 ± 0.3

0.339

BMI, kg/m2

17.0 ± 4.1

17.8 ± 3.2

18.0 ± 3.5

0.864

SBP, mmHg

106.3 ± 11.1

101.6 ± 10.3

106.0 ± 14.1

0.190

DBP, mmHg

68.4 ± 8.3

56.9 ± 12.8*

67.0 ± 10.0&

0.008

Waist-to-hip ratio

–

0.8 ± 0.1

0.8 ± 0.1

0.370

Diabetes duration, years

–

3.6 (2.0, 5.4)

3.0 (3.0, 5.5)

0.267

Age at diagnosis, years

–

7.2 ± 2.8

8.1 ± 3.4

0.137

FBG, mmol/L

–

5.6 (4.5, 11.4)

8.3 (5.0, 11.4)&

0.010

TC, mmol/L

–

4.0 ± 0.6

4.5 ± 1.1

0.212

TG, mmol/L

–

0.6 ± 0.1

0.9 (0.6, 1.2)&

< 0.001

HDL, mmol/L

–

1.8 ± 0.4

1.5 ± 0.4&

0.012

LDL, mmol/L

–

2.0 ± 0.6

2.5 (1.9, 2.9)&

0.009

ApoA1, g/L

–

1.6 ± 0.2

1.5 ± 0.3

0.090

Urea Nitrogen, mmol/L

–

5.4 (4.4, 6.1)

5.1 (4.1, 5.8)

0.109

Creatinine, μmmol/L

–

39.0 (33.5, 49.0)

38.0 (34.0, 38.0)

0.608

Uric Acid, μmol/L

–

276.0 (213.5, 315)

282.0 (221.0, 328.8)

0.470

Cystatin C, mg/L

–

0.8 ± 0.1

0.8 ± 0.1

0.664

  1. BSA body surface area, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fast blood glycemia, TC total cholesterol, TG triglycerides, HDL high-density lipoprotein, LDL low-density lipoprotein. *p < 0.05 compared to controls, &p < 0.05 compared to patients with HbA1c < 7.0%
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840